rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
2007-3-9
|
pubmed:abstractText |
Serum alpha-fetoprotein (AFP) is the most important tumor marker for hepatocellular carcinoma (HCC). Previous reports indicated that HCC was also associated with increased levels of interleukin (IL)-6, IL-10 and hepatocyte growth factor (HGF). This study investigated the role of these cytokines as tumor markers for HCC.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0748-7983
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
33
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
208-12
|
pubmed:dateRevised |
2007-7-2
|
pubmed:meshHeading |
pubmed-meshheading:17140760-Adult,
pubmed-meshheading:17140760-Angiography,
pubmed-meshheading:17140760-Carcinoma, Hepatocellular,
pubmed-meshheading:17140760-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:17140760-Female,
pubmed-meshheading:17140760-Follow-Up Studies,
pubmed-meshheading:17140760-Hepatocyte Growth Factor,
pubmed-meshheading:17140760-Humans,
pubmed-meshheading:17140760-Interleukin-10,
pubmed-meshheading:17140760-Interleukin-6,
pubmed-meshheading:17140760-Liver Neoplasms,
pubmed-meshheading:17140760-Male,
pubmed-meshheading:17140760-Middle Aged,
pubmed-meshheading:17140760-Neoplasm Staging,
pubmed-meshheading:17140760-Prognosis,
pubmed-meshheading:17140760-Prospective Studies,
pubmed-meshheading:17140760-Severity of Illness Index,
pubmed-meshheading:17140760-Tomography, X-Ray Computed,
pubmed-meshheading:17140760-Tumor Markers, Biological
|
pubmed:year |
2007
|
pubmed:articleTitle |
Evaluation of interleukin-6, interleukin-10 and human hepatocyte growth factor as tumor markers for hepatocellular carcinoma.
|
pubmed:affiliation |
Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|